JGJuan Martín Gutiérrez

Juan Martín Gutiérrez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Juan Martín Gutiérrez has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    La fibromialgia vista por los médicos especialistas en medicina de dolor en Colombia

    by Daniel G. Fernández-Ávila, Diana María Ronderos-Botero, Diana N. Rincón-Riaño, Juan M. Gutiérrez

    Introducción: Los conceptos y las percepciones sobre el diagnóstico y el tratamiento de la fibromialgia, entre los médicos especialistas en medicina del dolor no se conocen objetivamente, lo cual nos motivo a llevar a cabo el presente estudio. Métodos: Estudio descriptivo de corte transversal. A través de un grupo focal en el que participaron dos reumatólogos, dos médicos especialistas en medicina del dolor, y un experto en métodos de investigación cualitativa, se diseñó una encuesta para evaluar las percepciones y conceptos que los médicos especialistas en medicina del dolor tienen sobre el diagnóstico y el tratamiento de la fibromialgia. La encuesta se aplicó de forma autoadministrada y anónima a través de un link en internet, el cual fue enviado a médicos especialistas en dolor, pertenecientes a la Asociación Colombiana Para el Estudio del dolor. Resultados: Encuesta aplicada a 81 médicos especialistas en medicina del dolor. 71.6% (n=58) considera que hay suficiente evidencia para considerar la fibromialgia como una enfermedad, 90.1% (n=73) usa los criterios ACR de 1990 para diagnosticar pacientes con fibromialgia y 60.5% (n=49) de los encuestados manifestó emplear los criterios de clasificación de 2010. Los medicamentos más formulados para manejo de fibromialgia son los antidepresivos (96.3%) seguido de anticonvulsivantes (88.9%) y analgésicos (84%). 84% de los médicos remite estos pacientes a psiquiatría y 63% al reumatólogo. Conclusión: El presente estudio muestra información acerca de las percepciones acerca del diagnóstico y tratamiento de fibromialgia entre un grupo de médicos especialistas en medicina del dolor colombianos.

  • Prevalencia y características demográficas del síndrome de Sjögren en Colombia, según información del Sistema Integral de Información de la Protección Social

    by Daniel G. Fernández-Ávila, Diana N. Rincón-Riaño, Santiago Bernal-Macías, Juan M. Gutiérrez Dávila, Diego Rosselli


  • Demographic and clinical characteristics of patients with ANCA-positive vasculitis in a Colombian University Hospital over a 12-year period: 2005–2017

    by Daniel G. Fernández-Ávila, Julián Rondón-Carvajal, Catalina Villota-Eraso, Juan Martín Gutiérrez-Dávila, Kateir Mariel Contreras-Villamizar

    Vasculitides associated with anti-neutrophil cytoplasmic antibodies are heterogeneous, systemic, low prevalence and high morbidity and mortality entities. They include granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis. In Latin America, there are few descriptive registries of these patients. The objective of the study was to describe the demographic and clinical characteristics and in-hospital morbidity and mortality of patients with vasculitis associated with anti-neutrophil cytoplasmic antibodies in a university hospital in Colombia. This was a cross-sectional descriptive study. We performed computer searches with terms related to patients with anti-neutrophil cytoplasmic antibody-associated vasculitis, between 2005 and 2017 who met the American College of Rheumatology classification criteria for vasculitis associated with anti-neutrophil cytoplasmic antibodies, and their clinical and laboratory characteristics. One hundred and six patients with anti-neutrophil cytoplasmic antibody-associated vasculitis were included in the study. The average age was 55 years, and 57.5% were women. In 68.8% of the cases, the diagnosis was made during hospitalization, with an average hospital stay of 16.6 days (± 12.22). The distribution by type of vasculitis was: granulomatosis with polyangiitis 52%, microscopic polyangiitis 45.2% and eosinophilic granulomatosis with polyangiitis 1.8%. Alveolar hemorrhage occurred in 35% of patients; 20.7% had variable renal involvement, of which 53.8% progressed to advanced kidney disease. Treatment included glucocorticoids 91.5%, cyclophosphamide 62.2%, plasmapheresis 14.1%, and 41.5% required renal replacement therapy. In-hospital mortality was 16.5%, Sepsis was the most common cause of death. We present clinical information on a group of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis; renal involvement was the the most common type of affectation. Both the clinical and serological characteristics of our registry were similar to those described in other Latin American and European cohorts, and a lower in-hospital mortality rate was evidenced.


  • Prevalence and demographic characteristics of Behcet disease in Colombia: data from the national health registry 2012–2016

    by Daniel G. Fernández-Ávila, Diana N. Rincón-Riaño, Santiago Bernal-Macías, Juan M. Gutiérrez Dávila, Diego Rosselli

    To estimate prevalence and describe the main demographic characteristics of Behcet disease in Colombia. Cross-sectional study, based on official Ministry of Health registry data. 523 cases of Behcet disease (ICD-10 code: M352) were reported between 2012 and 2016, for a prevalence in people over 18 years old of 1.10 per 100,000 inhabitants, of which 68% are women, with a female-to-male ratio of 2.2:1, with greater prevalence within the 45–49 age group. This is the first study that shows demographic and epidemiological information on Behcet disease in Colombia. Prevalence seems to be low when compared with other similar studies in the region.


  • Prevalence of systemic sclerosis in Colombia: Data from the National Health Registry 2012–2016

    by Daniel G Fernández-Ávila, Santiago Bernal-Macías, Juan M Gutiérrez, Diana N Rincón, Diego Rosselli

    Introduction: Systemic sclerosis is an autoimmune disease that characteristically presents with fibrosis and vasculopathy. In Latin America, the information on the epidemiology of this disease is scarce and records are essential to know its behavior in the populations. In Colombia, the Ministry of Health uses the SISPRO tool to collect information on the unified national health system which offers nearly universal coverage (around 95%). This public information makes it possible to perform epidemiological studies on different diseases. Objectives: Using the SISPRO data corresponding to the years 2012–2016, we analyzed the prevalence and characteristics of patients with systemic sclerosis. Methods: A descriptive cross-sectional study was performed based on the SISPRO data; we used as keywords the diagnoses of the International Classification of Diseases related to the diagnosis of systemic sclerosis. Results: A total of 11,300 individuals diagnosed with systemic sclerosis were documented. The estimated prevalence was 23.7 cases per 100,000 inhabitants (based on a total population of 47,663,162); this disease is more frequent in the age group of 65–69 years in females (77%), and has a female:male ratio of 3.27:1. Conclusion: This study describes the epidemiological characteristics of systemic sclerosis in Colombia, based on official statistics from the Ministry of Health. The results provide a new vision of this disease in Latin America and open the door to future research, in order to better understand the particular characteristics of this disease in our country and our region.


  • Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia

    by Daniel G. Fernández-Ávila, Diana N. Rincón-Riaño, Diego F. Pinzón, Juan M. Gutiérrez Dávila

    Our study describes the clinical characteristics of patients with fragility fractures. It also shows there is a low knowledge about osteoporosis and its relation to fractures, in addition to the very poor adherence to medical advice and treatment.


  • Prevalence of polymyalgia rheumatica in Colombia: data from the national health registry 2012–2016

    by Daniel G. Fernández-Ávila, Santiago Bernal-Macías, Diana N. Rincón-Riaño, Juan M. Gutiérrez, Diego Rosselli


  • Open Access

    THU0665 PREVALENCE OF RHEUMATIC DISEASES IN COLOMBIA: AN APPROACH FROM MINISTRY OF HEALTH AND SOCIAL PROTECTION DATA (SISPRO)

    by Daniel G. Fernández-Ávila, Santiago Bernal-Macias, Diana Rincón, Juan Gutiérrez

    Background: The ministry of health and social protection of Colombia uses a system named SISPRO as a tool to establish the basic information of the health system. This information is public and available for anyone to search. We analyze the prevalence and specific characteristics of patients with rheumatic diseases registered in colombian health system between 2012 to 2016. Objectives: To establish the prevalence and basic epidemiological characteristics of the main rheumatic diseases in Colombia Methods: This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problem (CDI), as keywords for each rheumatic disease during the analysis of SISPRO data and National Statistical System (DANE) populations projections, as from the last census in Colombia to estimated prevalence of each disease. Results: Colombia is a middle-income country with an estimated population of 49.834.240 habitants to 2018 according to 2005 census projections. Despite some limitations of SISPRO data, actually is the only official database of the government. We calculate the estimated prevalence and number of patients with some rheumatic diseases (table 1), confirming that autoimmune diseases are more frequent in woman, and surprisingly, spondyloarthritis (ankylosing, psoriasis and inflammatory bowel disease) are also discreetly more frequent in woman population. Prevalence of rheumatic diseases in Colombia Conclusion: Epidemiological and prevalence information of rheumatic diseases in Colombia is presented. The data found in the present study are concordant with epidemiological studies in other countries. Disclosure of Interests: : None declared


  • Open Access

    AB0585 REJA-VASCA: JAVERIAN REGISTRY OF PATIENTS WITH POSITIVE ANCA VASCULITIS AT THE UNIVERSITY HOSPITAL SAN IGNACIO 2005–2017

    by Daniel G. Fernández-Ávila, Catalina Villota, Julián Rondón, Juan Gutiérrez

    Background: Vasculitis associated with cytoplasmic antibodies (VAAC) are heterogeneous entities with low prevalence and high morbidity and mortality. These include granulomatosis with polyangiitis (GPA), microscopic polyangiitis (PAM), and eosinophilic granulomatosis with polyangiitis (GEPA). European retrospective records report an annual incidence of 10-20 cases per million, with peak presentation between 65-74 years, predominantly in males. It has diverse clinical manifestations in multiple systems. In Colombia, there are few clinical records that describe the clinical characteristics of these patients. Objectives: To describe the clinical characteristics of patients with VAAC in the University Hospital San Ignacio between 2005-2017 Methods: Descriptive cross-sectional study. Patient records were reviewed between January 2005 and December 2017. The records were obtained using search systems in patients who were requested Antineutrophil cytoplasmic antibodies - ANCAS (Searching softeare: DISEARCH, LABCORE), obtaining 2072 results. 106 patients met the criteria for classification of the American College of Rheumatology for VAAC. Results: 106 patients diagnosed with ANCA positive vasculitis. Average age 55 years (± 14.7). 48.4% were women. In-hospital debut in 68.8%. The average number of days of stay was 16.6 days (± 12.22), 56 patients (52.8%) had granulomatosis with polyangiitis GPA, 45 patients (42.4%) with microscopic polyangiitis (MAP) and 5 patients with eosinophilic granulomatosis with polyangiitis EGP (4.8%). 37 patients (35%) presented with alveolar hemorrhage, 22 patients (20.7%) presented renal compromise with rapidly progressive glomerulonephritis. Central nervous system compromise was documented in 25 patients (24%). Regarding treatment, 97 patients (91.5%) received treatment with intravenous or oral corticosteroid, 66 patients (62.2%) received treatment with cyclophosphamide. Plasma exchange therapy was performed in 15 patients (14.1%). 44 patients (41.5%) required renal replacement therapy. The in-hospital mortality of this group of patients was 20.4%, with sepsis being the most frequent cause of death (55%). Conclusion: In this study, the most frequent positive ANCA vasculitis was granulomatosis with polyangiitis. Multisystemic compromise was present in all groups of patients, the most common being pulmonary and renal, mainly in patients with microscopic polyangiitis, similar to that reported by Solans-Laqué et al in Spain. Within the demographic characteristics, the average age at the time of diagnosis is around 50 years, predominantly in women related to the Mexican study by Hinojosa-Azaola et al. The most frequent cause of in-hospital mortality was sepsis. Clinical information of patients with VAAC is presented in a reference hospital in Colombia. Data are concordant with literature. Disclosure of Interests: None declared

  • Validation and calibration to Spanish of the Compliance Questionnaire on Rheumatology in a group of Colombian patients on treatment for rheumatoid arthritis

    by Daniel Gerardo Fernández-Avila, Melissa Accini, Manuela Tobón, Socorro Moreno, Viviana Rodríguez, Juan Martín Gutiérrez